PARTIAL LIPODYSTROPHY
Clinical trials for PARTIAL LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new PARTIAL LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for PARTIAL LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could blocking growth hormone help people with severe insulin resistance?
Disease control Recruiting nowThis study tests a drug called pegvisomant that blocks growth hormone in people with severe insulin resistance caused by lipodystrophy or insulin receptor gene changes. Participants will give themselves daily shots for one month and have two short hospital stays for tests. The go…
Matched conditions: PARTIAL LIPODYSTROPHY
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Real-World data sought on rare fat disorder drug
Knowledge-focused Recruiting nowThis study is a registry that collects information from people with generalized or partial lipodystrophy who are already taking the drug metreleptin. The goal is to monitor safety events like pancreatitis, liver problems, and infections over time. No new treatment is being tested…
Matched conditions: PARTIAL LIPODYSTROPHY
Sponsor: Amryt Pharma • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC